Abstract
Recent studies have suggested that MAP kinase phosphatase 1 (MKP-1) is overexpressed in prostate cancer. To evaluate the role of MKP-1 in regulating cell death and tumor growth in prostate cancer, MKP-1 was conditionally overexpressed in the human prostate cancer cell line DU145. Overexpression of MKP-1 in DU145 cells blocked activation of stress-activated protein kinase (SAPK/JNK). MKP-1 overexpression in DU-145 cells was also found to inhibit Fas ligand (FasL)-induced apoptosis, as well as block the activation of caspases by Fas engagement. In addition, MKP-1 blocked the activation of apoptosis by transfected MEKK-1 and ASK-1, presumably through its inhibition of the SAPK/JNK family of enzymes. MKP-1 blocked the ability of FasL to induce loss of mitochondrial transmembrane potential (Δγm), suggesting that MKP-1 acts upstream of mitochondrial pro-apoptotic events induced by FasL and that the SAPK/JNK pathway may form the signaling link between Fas receptor and mitochondrial dysfunction. Thus, MKP-1 overexpression in prostate cancer may play a role in promoting prostate carcinogenesis by inhibiting FasL-induced cell death.
Similar content being viewed by others
References
Denmeade R, Liu XS and Isaacs JT: Role of programmed cell death during the progression and therapy of prostate cancer. Prostate 28: 251–265, 1996
Suzuki A, Matsuzawa A and Iguchi T: Down regulation of bcl-2 is the first step in Fas-mediated apoptosis of male reproductive tract. Oncogene 13: 31–37, 1996
Nagata S: Apoptosis by death factor. Cell 88: 355–365, 1997
Yang X, Khosravi-Far R, Chang HY and Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067–1076, 1997
Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E and Sanchez I: Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 94: 3302–3307, 1997
Sun H, Charles CH, Lau LF and Tonks NK: MKP-1 (3CH134), an immediate early gene product is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487–493, 1993
Franklin CC and Kraft AS: Conditional expression of the mitogenactivated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272: 16917–16923, 1997
Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Whishnow K, Kaplan I, Stork PJ and Loda M: MKP-1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest 76: 37–54, 1997
Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigoioni W, Wang Y, Magi-Galluzzi C and Stork PJ: Expression of MKP-1 in early phases of human epithelial carcinogenesis. Am J Path 149: 1553–1562, 1996
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K, Krammer PH and Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675–1687, 1998
Hedlund TE, Duke RC, Schleicher MS and Miller GJ: Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage. Prostate (In Press)
Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med 183: 1293–1295, 1996
Rosette C and Karin M: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274: 1194–1197, 1996
Franklin CC, Srikanth S and Kraft AS: Conditional expression of mitogen-activatec protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc Natl Acad Sci USA 95: 3014–3019, 1998
Thomas DJ and Caffrey TC: LPS induces double-stranded DNA fragmentation in mouse thymus: protective effect of zinc pretreatment. Toxicology 68: 327–337, 1991
Perry DK, Smyth MJ, Stennicke HR, Salvesen GS, Duriez P, Poirier GG and Hannun YA: Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem 272: 18530–18533, 1997
Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331
Cardone MH, Salvesen GS, Weidmann C, Johnson G and Frisch SM: The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90: 315–323, 1997
Ichijo H, Nishida E, Irie K, Dijke Pt, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90–94, 1997
Chang HY, Nishitoh H, Yang X, Ichijo H and Baltimore D: Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281: 1860–1863, 1998
Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM: FLICE, a novel Fadd-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) deathinducing signaling complex. Cell 85: 817–827, 1996
Boldin MP, Gancharov TM, Goltsev YV and Wallach D: Involvement of MACH, a novel Mort1/Fadd-Interacting protease in Fas/ APO-1-and TNF receptor-induced cell death. Cell 85: 803–815, 1996
Rehemtulla A, Hamilton CA, Chinnaiyan AM and Dixit VM: Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 272: 25783–25786, 1997
Guo Y-L, Kang B and Williamson JR: Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J Biol Chem 273: 10362–10366, 1998
Liu Z-g, Hsu H, Boeddel DV and Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death. Cell 87: 565–576, 1996
Natoli G, Costanze A, Ianni A, Templeton D, Woodgett JR, Balsano C and Levrero M: Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200–203, 1997
Haldar S, Chintapalli J and Croce CM: Taxol induces bcl-2 phosphorylation and death of prostrate cancer cells. Cancer Res 56: 1253–1255, 1996
Chang BS, Minn AJ, Muchmore SW, Fesik SW and Thompson CB: Identification of a novel regulatory domain in Bcl-xL and Bcl-2. EMBO J 16: 968–977, 1997
Haldar S, Jena N and Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507–4511, 1995
Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Marinou J-C and Arkinstall S: Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stressactivated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem 272: 25238–25242, 1997
Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K and Ichijo H: ASK1 is essential for JNK/SAPK activation of TRAF2. Mol Cell 2: 389–395, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Srikanth, S., Franklin, C.C., Duke, R.C. et al. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol Cell Biochem 199, 169–178 (1999). https://doi.org/10.1023/A:1006980326855
Issue Date:
DOI: https://doi.org/10.1023/A:1006980326855